How can private practice in healthcare be balanced with the need for a comprehensive and equitable healthcare system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Balancing private practice in healthcare with the need for a comprehensive and equitable system requires a mixed model approach that prioritizes universal access and quality of care, as evidenced by the most recent study on value-based payment for clinicians treating cardiovascular disease 1. This approach can be achieved by implementing tiered coverage systems, where basic healthcare is guaranteed to all citizens through public funding, while allowing private options for supplementary services. Key considerations include:

  • Regulated fee structures to prevent exploitation and ensure affordability
  • Public-private partnerships to enhance access to care in underserved areas
  • Incentive programs that encourage private practitioners to serve diverse patient populations
  • Clear quality standards and oversight mechanisms to ensure equity and excellence in care
  • Sliding scale payment systems based on income levels to make services accessible to all population segments

The success of such systems in countries like Australia, Germany, and France demonstrates that private practice can coexist with universal coverage when properly regulated and integrated within a cohesive national healthcare strategy. As noted in the American College of Physicians' policy position paper on direct patient contracting practices 1, there is a need for high-quality, independent research on the effect of private practice models on quality and access. However, the most recent guidance from the American Heart Association on value-based payment for clinicians treating cardiovascular disease 1 emphasizes the importance of designing payment systems that promote equity and improve patient outcomes, particularly for high-risk groups. By prioritizing these principles and leveraging the strengths of both private and public sectors, it is possible to create a balanced and equitable healthcare system that meets the needs of all patients.

From the Research

Balancing Private Practice in Healthcare with Comprehensive and Equitable Systems

  • The resurgence of private practice in healthcare raises concerns about balancing individualized care with the need for a comprehensive and equitable healthcare system 2.
  • Studies have shown that private practice physicians face increasing competition from larger practices and hospitals, leading to decreased reimbursement rates and longer working hours 2.
  • To address these challenges, private practices may consider expanding their services, forming alliances, and exploring merger opportunities 2.

Role of Technology in Private Practice

  • Telehealth interventions have been shown to improve medication adherence for patients with chronic conditions such as type 2 diabetes, hypertension, and dyslipidemia 3.
  • Electronic health (eHealth) and telehealth interventions can increase health literacy and improve medication possession ratio (MPR) and proportion of days covered (PDC) rates 3.
  • The use of technology can enhance the quality of care provided by private practices and improve patient outcomes.

Primary Care Access and Capabilities

  • A study on US primary care practices found that access to care declined during the COVID-19 pandemic, while practice capabilities improved 4.
  • Integrated practice ownership and accountable care organization (ACO) participation were associated with better access and capability scores, suggesting that value-based payment and integrated care delivery support high-quality primary care 4.
  • Private practices can learn from these findings and strive to improve their capabilities and access to care.

Management of Chronic Conditions

  • The management of hyperlipidemia in diabetes is crucial for reducing the risk of coronary heart disease (CHD) 5.
  • Combination therapy with metformin and atorvastatin has been shown to be effective in improving HbA1c and LDL-C levels in patients with type 2 diabetes and dyslipidemia 6.
  • Private practices can play a critical role in managing chronic conditions such as diabetes and dyslipidemia by providing comprehensive and coordinated care.

Related Questions

What are the brand names of the most commonly prescribed 100 pharmaceuticals (medications) in the United States of America (USA)?
What is the relationship between diabetes and atorvastatin (Lipitor)?
Is adjusting insulin, adding atorvastatin, increasing metformin, and performing a foot exam a suitable diabetes management plan?
What is the cause of cold-like symptoms in a patient with newly diagnosed type 2 diabetes mellitus and hypercholesterolemia, started on Atorvastatin (Atorvastatin) 20 mg and Metformin (Metformin) extended release (ER) 500 mg?
What is the plan of care for a 65-year-old female patient with type 2 diabetes (T2D), hypertension (HTN), and hyperlipidemia, presenting with elevated blood pressure, slight dehydration, increased Hemoglobin A1C (HbA1C), elevated cholesterol, decreased High-Density Lipoprotein (HDL), and taking vitamin D, metformin, lovastatin, Jardiance (empagliflozin), levothyroxine, enalapril, and famotidine?
What is the initial treatment for a patient diagnosed with pyelonephritis (inflammation of the kidney)
What is the initial treatment for IgG4 (Immunoglobulin G4) pancreatitis?
What is the most appropriate test to quantify proteinuria in a patient with impaired renal function and significant proteinuria?
What is the initial treatment for IgG4 (Immunoglobulin G4) pancreatitis?
What is the role of Adipose-Derived Stem Cells (ADSC) exosomes in treating orthopedic conditions like osteoarthritis and tendonitis?
What is the diagnosis and management for a patient with reduced Forced Expiratory Volume in 1 second (FEV1) to Forced Vital Capacity (FVC) ratio and decreased Maximum Expiratory Flow (MEF) values?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.